Prothix is a Dutch biopharmaceutical company focused on the development of protein therapeutics in the field of coagulation and inflammation. Product leads, discovered by the company or licensed in from academia, are selected based on medical need, potential markets and customer needs and meet a so-called niche-buster profile, i.e. they will be developed for niche indications to obtain clinical proof of concept, while having blockbuster promise for other indications. Prothix adds value to these leads by executing preclinical proof of concept and early development studies.
| Website | http://www.prothix.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 2008 |
| Phone | +31 6 20277623 |
| Industry | Business Services General, Commercial, Pharmaceuticals, Business Services, Drug Discovery |
| Competitors | Iovate, Provenance Biopharmaceuticals, Abbott, Zymergen, Inc., Syndax Pharmaceuticals, Valo, SUN PHARMA, Geno, REVOLUTION Medicines, bluebird bio +35 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular Prothix BV employee's phone or email?
Prothix BV Questions
The Prothix BV annual revenue was $5 million in 2026.
The NAICS codes for Prothix BV are [541713, 541, 54, 5417, 54171].
The SIC codes for Prothix BV are [87, 873].
